monitored empagliflozin treatment in an 11-year old girl, following the reduction of 1,5-AG levels; concurrently, neutrophil counts and function improved, as well as her IBD symptoms with reduction of G-CSF dose. Here, CSF3 is linked to inflammatory bowel disease.